rs397508459
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_000492.4(CFTR):c.2916_2917delTCinsAT(p.Leu973Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.2916_2917delTCinsAT | p.Leu973Phe | missense_variant | ENST00000003084.11 | NP_000483.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cystic fibrosis Uncertain:2Other:1
The c.2916_2917delTCinsAT variant (also known as p.L973F and 3048_3049delTCinsAT), located in coding exon 18 of the CFTR gene, results from an in-frame deletion of TC and insertion of AT between nucleotide positions 2916 and 2917. This results in the substitution of the leucine residue for a phenylalanine residue at codon 973, an amino acid with highly similar properties. This variant was reported in conjunction with the c.2657+5G>A pathogenic mutation in a male with congenital absence of the vas deferens (Dörk T et al. Hum. Genet., 1997 Sep;100:365-77). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be inconclusive by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. -
- -
- -
not specified Uncertain:1
Variant summary: CFTR c.2916_2917delinsAT (p.Leu973Phe) results in a conservative amino acid change located in the transmembrane domain (IPR011527) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 245824 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.2916_2917delinsAT has been reported in the literature in an individual affected with Congenital Bilateral Absence of the Vas Deferens (CBAVD), with a pathogenic variant, c.2657+5G>A, in trans (Dork 1997). These data do not allow clear conclusions about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at